Saniona AB (publ) (SANION.ST) News
Track canonical SquawkNews coverage tagged to SANION.ST, Saniona AB (publ). This hub brings together deduplicated headlines about stockholm, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 3 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Saniona completes SAN2465 tox, CMC studies, targets IND filing by end — October 2026
Saniona completed toxicology and CMC work for SAN2465, clearing the package needed to support an IND filing. IND submission to the FDA is targeted by end-October 2026, setting up first-in-human dosing plans. Planned Phas
REGULATION | Sep 24, 2026, 06:05 AM UTC
L
Saniona targets FDA IND filing for SAN2465 by end — October 2026
Saniona completed required toxicology and CMC work for SAN2465, clearing the way for a US IND filing by end-October 2026. The company is finalizing IND documentation for submission to the FDA. A planned Phase 1 trial wou
REGULATION | Sep 24, 2026, 06:05 AM UTC
L
BRIEF — Saniona Completes Toxicology And Cmc Studies For San2465 Ind Application
Sept 24 (Reuters) — Saniona AB: Completes Toxicology And Cmc Studies For San2465 Ind Application Expects To Submit San2465 Ind Application To Fda Before End Of October 2026 Source text:... Further company coverage: SANIO
REGULATION | Sep 24, 2026, 06:03 AM UTC